Evidence map›Paper›PMID 35814618›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2022

Vascular and microstructural markers of cognitive pathology.

Claudia Coffin, Cynthia K Suerken, James R Bateman, Christopher T Whitlow, Benjamin J Williams, Mark A Espeland, Bonnie C Sachs, Maryjo Cleveland, Mia Yang, Samantha Rogers and 6 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Adverse childhood experiences influence markers of neurodegeneration risk in older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  9. Article
  10. Article
  11. Evaluation of plasma p-tau217 for detecting amyloid pathology in a heterogeneous community-based cohort.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  12. Article
  13. Social support may buffer the effect ofJournal of Alzheimer's disease : JAD · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Claudia CoffinDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Cynthia K SuerkenDepartment of Biostatistics and Data Science Division of Public Health Sciences Wake Forest School of Medicine Winston-Salem North Carolina USA.
James R BatemanDepartment of Neurology Wake Forest School of Medicine Winston-Salem North Carolina USA.
Christopher T WhitlowDepartment of Radiology Wake Forest School of Medicine Winston-Salem North Carolina USA.
Benjamin J WilliamsDepartment of Neurology Wake Forest School of Medicine Winston-Salem North Carolina USA.
Mark A EspelandDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Bonnie C SachsDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Maryjo ClevelandDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Mia YangDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Samantha RogersDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Kathleen M HaydenDepartment of Social Sciences and Health Policy Division of Public Health Sciences Wake Forest School of Medicine Winston-Salem North Carolina USA.
Laura D BakerDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Jeff WilliamsonDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Suzanne CraftDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Timothy M HughesDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.
Samuel N LockhartDepartment of Internal Medicine Section on Gerontology and Geriatric Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.

Funding

Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)R01AG058969 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Timothy M. Hughes, YONGMEI LIU · 2018 to 2026
$33.4M
Wake Forest University School of Medicine Alzheimer's Disease Research CenterP30AG072947 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SUZANNE CRAFT · 2021 to 2026
$24.3M
Wake Forest Alzheimer's Disease Core CenterP30AG049638 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ESPELAND, MARK ANDREW · 2016 to 2020
$12.2M
The Macrovascular and Microvascular Contributions to Alzheimer's Disease: MESA VASCADR01AG054069 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HUGHES, TIMOTHY M. · 2016 to 2020
$3.8M
NIA NIH HHS P30 AG049638NIA NIH HHS P30 AG072947NIA NIH HHS R01 AG054069NIA NIH HHS R01 AG058969
6 · The paper itself

Abstract

Introduction: Arterial stiffness may play a role in the development of dementia through poorly understood effects on brain microstructural integrity and perfusion. Methods: We examined markers of arterial stiffness (carotid-femoral pulse wave velocity [cfPWV]) and elevated systolic blood pressure (SBP) in relation to cognitive function and brain magnetic resonance imaging macrostructure (gray matter [GM] and white matter [WM] volumes), microstructure (diffusion based free water [FW] and fractional anisotropy [FA]), and cerebral blood flow (CBF) in WM and GM in models adjusted for age, race, sex, education, and apolipoprotein E ε4 status. Results: Among 460 participants (70 ± 8 years; 44 dementia, 158 mild cognitive impairment, 258 normal cognition), higher cfPWV and SBP were independently associated with higher FW, higher WM hyperintensity volume, and worse cognition (global and executive function). Higher SBP alone was significantly associated with lower WM and GM CBF. Discussion: Arterial stiffness is associated with impaired WM microstructure and global and executive cognitive function.

Indexed as

arterial stiffnesscognitionhypertensionmagnetic resonance imagingneurite orientation density and dispersion imagingneuroimagingwhite matter

Identifiers

PMID35814618
PMCPMC9257520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.